BVF »

Crescent Biopharma shares owned by BVF

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by BVF from 13F filings

Historical chart of BVF investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by BVF

Quarter filed Position value Share count Share price at filing
2025-12-31 $33M 2.7M 11.86
2025-09-30 $17M 1.4M 11.89
2025-06-30 $22M 1.4M 16.14

More positions owned by BVF

Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Structure Therapeutics Sponsored Ads (GPCR)
Olema Pharmaceuticals (OLMA)
Mirum Pharmaceuticals (MIRM)
Gh Research Ordinary Shares (GHRS)
Xencor (XNCR)
Zymeworks Del (ZYME)
Palvella Therapeutics Inc Ne (PVLA)
Kura Oncology (KURA)
Stoke Therapeutics (STOK)
Xoma Royalty Corporation Com New (XOMA)
Abivax Sa Sponsored Ads (ABVX)
Nektar Therapeutics Com New (NKTR)

View all positions for BVF

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Vestal Point Capital
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Deep Track Capital
Perceptive Advisors
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma